CLOSED STUDIES / Ovarian Cancer


GEICO 0101


Title

Phase III clinical trial to evaluate treatment with the combination of cisplatin plus topotecan followed by paclitaxel plus carboplatin versus paclitaxel plus carboplatin as the first-line treatment in women with recent diagnosis of advanced epithelial ovarian cancer.


GEICO Coordinator

Dr. Miguel Angel Izquierdo / Dr. Andres Cervantes


Patients Recruited

129 patients


Inclusion Closing Date

June of 2005


Publication

Hoskins PJ, Vergote I, Stuart G, et al.: A phase III trial of cisplatin plus topotecan followed by paclitaxel plus carboplatin versus standard carboplatin plus paclitaxel as first-line chemotherapy in women with newly diagnosed advanced epithelial ovarian cancer (EOC) (OV.16). A Gynecologic Cancer Intergroup Study of the NCIC CTG, EORTC GCG, and GEICO. [Abstract] J Clin Oncol 26 (Suppl 15): A-LBA5505, 2008.